Multinational Pharma

6 posts

Recent Drug Safety Alerts – Asrar Qureshi’s Blog Post #1125

Asrar Qureshi’s Blog Post 1125 discusses post-marketing surveillance and pharmacovigilance efforts in reporting adverse drug reactions. It highlights recent FDA warnings about cetirizine, scopolamine patches, and mRNA COVID-19 vaccines concerning severe side effects, urging that this information be treated as essential for discussions among healthcare professionals.
Share
View Post
  • 5 min

Bad Bosses and Mental Health – How to Save Yourself – Asrar Qureshi’s Blog Post #1097

Asrar Qureshi’s Blog Post #1097 discusses the negative impact of bad bosses on mental health, highlighting issues like chronic stress, lack of recognition, toxic communication, and unfairness. It suggests organizational strategies like leadership training and mental health programs, along with employee actions such as setting boundaries and seeking support, to combat toxic leadership.
Share
View Post
  • 5 min

Colossal Wrongdoings by Big Pharma – GSK – Asrar Qureshi’s Blog Post #1090

Asrar Qureshi’s blog post on Pharma Veterans highlights the systemic issues within the pharmaceutical industry, exemplified by GlaxoSmithKline’s $3 billion settlement for fraud and misconduct in 2012. The case underscores the need for stronger regulatory oversight, ethical practices, and whistleblower protection to prevent future harmful corporate behavior in healthcare.
Share
View Post
  • 6 min

Interview Excerpts Ex-CEO Novartis – Asrar Qureshi’s Blog Post #1077

Dr. Daniel Vasella, former CEO of Novartis, shares insights on leadership challenges, organizational culture, and the importance of empathy and work-life balance. He emphasizes vulnerability, approachability, and continuous self-improvement for leaders. Coaching is now essential for CEOs, reflecting a shift towards a more collaborative leadership style appealing to younger generations.
Share